United States Food and Drug Administration
PulseAugur coverage of United States Food and Drug Administration — every cluster mentioning United States Food and Drug Administration across labs, papers, and developer communities, ranked by signal.
- parent of Center for Biologics Evaluation and Research 100%
- parent of Center for Drug Evaluation and Research 100%
- subsidiary of United States Department of Health and Human Services 100%
- parent of Center for Devices and Radiological Health 100%
- employed by Kyle Diamantas 90%
- acquired Eli Lilly and Company 90%
- developed by Revolution Medicines (United States) 90%
- developed by daraxonrasib 90%
- affiliated with United States Centers for Disease Control and Prevention 70%
- employed by Marty Makary 70%
- affiliated with Kyle Diamantas 70%
- used by FDA Adverse Event Reporting System 70%
- 2026-08-11 regulatory The FDA proposed a rule change requiring food manufacturers to notify regulators before introducing new ingredients or additives. source
- 2026-07-24 regulatory A panel of FDA advisers narrowly recommended easing restrictions on several peptides, despite warnings from government scientists. source
- 2026-07-23 product_launch The FDA launched an AI platform that is now used daily by 85% of its staff. source
- 2026-07-22 regulatory An FDA panel is reviewing seven peptides, with a decision on their potential legalization expected soon. source
- 2026-07-21 regulatory The FDA's Pharmacy Compounding Advisory Committee will review seven peptides to determine their eligibility for compounding. source
- 2026-07-21 regulatory The FDA is reviewing seven peptides for potential compounding approval, facing scrutiny over safety and efficacy claims. source
- 2026-07-20 controversy The FDA is investigating a Cyclospora outbreak and maintains Taylor Farms lettuce is the likely source, despite retracting an earlier positive test result. source
- 2026-07-20 regulatory The FDA retracted a positive test result linking Taylor Farms' lettuce to a cyclospora outbreak. source
- 2026-07-20 regulatory The FDA's compounding advisory committee is set to review seven peptides, potentially paving the way for a new market in wellness injectables. source
- 2026-07-15 regulatory The FDA proposed easing prescribing limits on testosterone gels, pills, patches, and injections. source
- 2026-07-03 regulatory The FDA ruled that ZYN nicotine pouches can be marketed as a less harmful alternative to cigarettes. source
- 2026-06-30 regulatory Hanmi Pharmaceutical's abbreviated new drug application (ANDA) for tirzepatide injection has been accepted for review by the U.S. FDA. source
- 2026-06-24 regulatory The FDA reached a compromise with Whoop Wearable regarding blood pressure monitoring, avoiding a shutdown of related features. source
- 2026-06-15 regulatory The FDA released draft guidance on AI in medical devices. source
- 2026-06-12 regulatory The FDA announced the first real-time clinical trial data system, enabled by widespread AI adoption. source
27 day(s) with sentiment data
-
AI breast cancer detection tools fail to meet radiologist expectations
A recent survey of radiologists indicates that current AI tools for breast cancer detection are not meeting expectations. While many radiologists are using these FDA-approved tools, they are not seeing the anticipated i…
-
Eli Lilly escalates fight against black market retatrutide
Eli Lilly & Co. is intensifying its efforts to combat the illicit market for retatrutide, an experimental weight-loss drug. The company has filed lawsuits against businesses in the US, particularly in Texas, that are il…
-
Google Pixel Watch 5 adds AI-powered blood pressure and insulin resistance tracking
Google has unveiled the Pixel Watch 5, featuring advanced health monitoring capabilities including blood pressure and insulin resistance tracking. The new Health Guardian feature utilizes AI to analyze trends from the w…
-
FDA broadens RWE guidance for medical devices, accepting de-identified data and primary evidence
The FDA has updated its guidance on real-world evidence (RWE) for medical devices, introducing two key structural changes that broaden the scope of permissible submissions. Firstly, the agency will now accept de-identif…
-
Greenland warns oil firm over illegal drilling; Samsung Buds to gain hearing aid feature
Greenland has issued a strong warning to an American oil firm for illegally drilling wells, as reported by TheGuardian.com. Separately, Samsung announced that its Galaxy Buds will soon feature a hearing aid capability, …
-
FDA report on recalled lettuce, PachiPals pre-orders, and Honkai: Star Rail character news
A report from the United States Food and Drug Administration has revealed that less than 2.5% of Taylor Farms' recalled lettuce was distributed to Taco Bell locations. This finding raises questions about the distributio…
-
Samsung Galaxy Buds to gain FDA-approved hearing aid feature
Samsung is set to release a hearing aid feature for its Galaxy Buds later this year, following FDA approval. This feature, designed for individuals aged 18 and over with mild to moderate hearing loss, will be available …
-
FDA proposes new rule for food additive notification
The U.S. Food and Drug Administration (FDA) has proposed a new rule that would require food manufacturers to notify the agency before introducing new ingredients or additives. This change aims to close a long-standing i…
-
Taylor Farms faces multi-pathogen food safety crisis impacting major brands
Taylor Farms is facing a significant food safety crisis, linked to multiple pathogen outbreaks affecting major U.S. brands. The company is involved in FDA investigations concerning a salmonella outbreak tied to jalapeño…
-
China gene therapy deaths spark global debate on safety and oversight
Two recent deaths in China linked to gene therapy trials have reignited debates surrounding transparency and regulatory oversight in the field. These incidents, occurring under China's investigator-initiated trial pathw…
-
FDA faces decision on popular peptides amid safety and efficacy concerns
The FDA is facing a critical decision regarding the authorization of six popular but experimental peptides, which are increasingly being used for health, fitness, and longevity despite limited scientific evidence. Onlin…
-
Taylor Farms recalls jalapeño products over salmonella risk
Taylor Farms is initiating a voluntary recall of certain products containing jalapeños due to a potential salmonella contamination. This action follows a recall by their supplier, Coast Citrus Distributors, who identifi…
-
Cyclospora outbreak linked to Mexican lettuce sparks consumer confidence crisis in US
A significant outbreak of Cyclospora infections, linked to iceberg lettuce from Mexico, has expanded to 15 U.S. states, causing over 25,000 reported cases and impacting consumer confidence in fresh produce. Retailers an…
-
Congress targets insulin costs and drug patent abuses
Congress is advancing legislation aimed at reducing prescription drug costs and reforming patent practices. The INSULIN Act, which has passed a key Senate committee, proposes capping out-of-pocket insulin costs at $35 p…
-
Deterministic AI governance proposed for critical food safety recalls
A new approach to AI governance is proposed for critical applications like food safety recalls, emphasizing a deterministic layer over probabilistic large language models (LLMs). The core idea is to separate the AI's na…
-
Risks of 'Barbie Peptide' Melanotan II highlighted by influencers
Melanotan II, also known as the 'Barbie peptide,' is being promoted by social media influencers for achieving a tan without sun exposure. This synthetic peptide mimics the body's alpha-melanocyte-stimulating hormone to …
-
Moderna's mRNA flu vaccine mFLUSIVA gains FDA approval for adults 50+
Moderna has received FDA approval for its mRNA-based flu vaccine, named mFLUSIVA. This vaccine is now authorized for use in all adults aged 50 and older. The approval followed a review process that was described as a "r…
-
Salmonella outbreak linked to Mexican jalapeños affects 345 people
A multistate salmonella outbreak, affecting at least 345 people across 27 states, has been traced to jalapeño peppers originating from a grower in Sinaloa, Mexico. Federal officials identified Coast Citrus Distributors …
-
Gas station 'energy supplements' found to contain potent opioids
Products sold as energy supplements at gas stations often contain potent opioids and other dangerous substances, an emergency physician reports. These items, which bypass pre-market safety approval under the Dietary Sup…
-
FDA approves Moderna's mRNA flu vaccine after initial review refusal · 2 sources tracked
The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, mFlusiva (mRNA-1010), for adults aged 50 and over. This approval follows an initial refusal by the FDA to review the application…